Publication
MAGI-3 competes with NHERF-2 to negatively regulate LPA2 receptor signaling in colon cancer cells
Downloadable Content
- Persistent URL
- Last modified
- 02/20/2025
- Type of Material
- Authors
- Language
- English
- Date
- 2011-03
- Publisher
- Springer Verlag (Germany)
- Publication Version
- Copyright Statement
- © 2011 AGA Institute. Published by Elsevier Inc. All rights reserved.
- License
- Final Published Version (URL)
- Title of Journal or Parent Work
- ISSN
- 1861-9681
- Volume
- 140
- Issue
- 3
- Start Page
- 924
- End Page
- 934
- Grant/Funding Information
- This work was supported by grants from the National Institutes of Health R01DK071597 and R01DK071597-03S1 (CCY) and R01NS055179 (RAH).
- National Institute of Diabetes and Digestive and Kidney Diseases : NIDDK
- Supplemental Material (URL)
- Abstract
- SUMMARY Background & Aims Lysophosphatidic acid (LPA) is a potent inducer of colon cancer and LPA receptor type 2 (LPA2) is overexpressed in colon tumors. LPA2 interacts with membrane-associated guanylate kinase with inverted orientation-3 (MAGI-3) and the Na+/H+ exchanger regulatory factor 2 (NHERF-2), but the biological effects of these interactions are unknown. We investigated the roles of MAGI-3 and NHERF-2 in LPA2-mediated signaling in human colon cancer cells. Methods We overexpressed or knocked down MAGI-3 in HCT116 and SW480 cells. The effects of MAGI-3 and NHERF-2 in LPA-induced cell migration, invasion, inositol phosphate generation, and NF-κB activation were determined. Expression of MAGI-3 and NHERF-2 in human colon tumor tissues was analyzed using tissue microarray analysis. Results NHERF-2 promoted migration and invasion of colon cancer cells, whereas MAGI-3 inhibited these processes. MAGI-3 competed with NHERF-2 for binding to LPA2 and phospholipase C (PLC)-β3. However, NHERF-2 and MAGI-3 reciprocally regulated LPA2-induced PLC activity. MAGI-3 increased the interaction of LPA2 with Gα12, whereas NHERF-2 preferentially promoted interaction between LPA2 and Gαq. MAGI-3 decreased the tumorigenic capacity of LPA2 by attenuating the activities of NF-κB and c-Jun N-terminal kinase. MAGI-3 and NHERF-2 were differentially expressed in colon adenocarcinomas, consistent with their opposing effects. Conclusion LPA2 is dynamically regulated by 2 distinct PDZ proteins via modulation of G protein coupling and receptor signaling. MAGI-3 is a negative regulator of LPA2 signaling.
- Author Notes
- Keywords
- Research Categories
- Health Sciences, Oncology
Tools
- Download Item
- Contact Us
-
Citation Management Tools
Relations
- In Collection:
Items
| Thumbnail | Title | File Description | Date Uploaded | Visibility | Actions |
|---|---|---|---|---|---|
|
|
Publication File - v0fmp.pdf | Primary Content | 2025-01-29 | Public | Download |